Nanotechnology: A successful approach to improve oral bioavailability of phytochemicals

Recent Patents on Drug Delivery and Formulation

Volumn 10, Issue 1, 2016, Pages 4-6

  Shakeri, Abolfazl ^a   Sahebkar, Amirhossein ^a,b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Bioavailability; Controlled release; Nanomedicine; Phytochemical; Solubility

Indexed keywords

CAMPTOTHECIN; CATECHIN; CRYPTOTANSHINONE; CURCUMIN; DAUNORUBICIN; DENDRIMER; ELLAGIC ACID; FULLERENE; FUROCOUMARIN; HYPERICIN; LIPOSOME; NANOCRYSTAL; NANOPARTICLE; PACLITAXEL; PLANT MEDICINAL PRODUCT; PODOPHYLLOTOXIN; PSORALEN; RESVERATROL; SILYMARIN; SOLID LIPID NANOPARTICLE; TETRANDRINE; TRIPTOLIDE; ZEOLITE;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; HYDROGEL; NANOEMULSION; NANOMEDICINE; PATENT; PRIORITY JOURNAL; ANIMAL; BIOAVAILABILITY; HUMAN; NANOTECHNOLOGY; ORAL DRUG ADMINISTRATION; PROCEDURES; TRENDS;

ADMINISTRATION, ORAL; ANIMALS; BIOLOGICAL AVAILABILITY; HUMANS; NANOTECHNOLOGY; PHYTOCHEMICALS;

EID: 84961683020     PISSN: 18722113     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872211309666150611120724     Document Type: Article

References (12)

1. Wang S, Su R, Nie S, Sun M, Zhang J, Wu D, et al. Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem 2014; 25: 363-76.
2. Sawant SV, Kadam DVJ, Jadhav DKR, Sankpal SV. Drug nanocrystals: Novel technique for delivery of poorly soluble drugs. Int J Sci Innov Discov 2011; 1: 1-15.
3. Kamble VA, Jagdale DM, Kadam VJ. Nanosuspension a novel drug delivery system. Int J Pharm BioSci 2010; 1.
4. Sanna V, Siddiqui IA, Sechi M, Mukhtar H. Nanoformulation of natural products for prevention and therapy of prostate cancer. Cancer lett 2013; 334: 142-51.
5. Thapa RK, Khan GM, Parajuli-Baral K, Thapa P. Herbal medicine incorporated nanoparticles: Advancements in herbal treatment. Asian J Biomed Pharm Sci 2013; 3: 7-14.
6. Bharali DJ, Siddiqui IA, Adhami VM, Chamcheu JC, Aldahmash AM, Mukhtar H, et al. Nanoparticle delivery of natural products in the prevention and treatment of cancers: Current status and future prospects. Cancers 2011; 3: 4024-45.
7. Munin A, Edwards-Lévy F. Encapsulation of natural polyphenolic compounds: A review. Pharmaceutics 2011; 3: 793-829.
8. Thassu D, Deleers M, Pathak YV. Nanoparticulate drug delivery systems. CRC Press; 2007.
9. Zhang X-Q, Xu X, Bertrand N, Pridgen E, Swami A, Farokhzad OC. Interactions of nanomaterials and biological systems: Implications to personalized nanomedicine. Adv Drug Deliv Rev 2012; 64: 1363-84.
10. Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? BioFactors 2013; 39: 197-208.
11. Sahebkar A, Chew GT, Watts GF. Recent advances in pharmacotherapy for hypertriglyceridemia. Prog Lipid Res 2014; 56: 47-66.
12. Naksuriya O, Okonogi S, Schiffelers RM, Hennink WE. Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment. Biomaterials 2014; 35: 3365-83.